Research ExplorerPublicationsHuman epidermal growth factor receptor 2 (HER2) in salivary ...

Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.

Standard

Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas. / Clauditz, Till; Reiff, Maren; Gravert, Linn; Gnoss, Alexander; Tsourlakis, Maria Christina; Münscher, Adrian; Sauter, Guido; Bokemeyer, Carsten; Knecht, Rainald; Wilczak, Waldemar.

In: PATHOLOGY, Vol. 43, No. 5, 5, 2011, p. 459-464.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Clauditz, T, Reiff, M, Gravert, L, Gnoss, A, Tsourlakis, MC, Münscher, A, Sauter, G, Bokemeyer, C, Knecht, R & Wilczak, W 2011, 'Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.', PATHOLOGY, vol. 43, no. 5, 5, pp. 459-464. <http://www.ncbi.nlm.nih.gov/pubmed/21670724?dopt=Citation>

APA

Clauditz, T., Reiff, M., Gravert, L., Gnoss, A., Tsourlakis, M. C., Münscher, A., Sauter, G., Bokemeyer, C., Knecht, R., & Wilczak, W. (2011). Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas. PATHOLOGY, 43(5), 459-464. [5]. http://www.ncbi.nlm.nih.gov/pubmed/21670724?dopt=Citation

Vancouver

Clauditz T, Reiff M, Gravert L, Gnoss A, Tsourlakis MC, Münscher A et al. Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas. PATHOLOGY. 2011;43(5):459-464. 5.

Bibtex

@article{39acaac078a6442f888e3b31b2ef6abb,
title = "Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.",
abstract = "HER2 is a target for antibody-based treatment of breast and gastric carcinoma which is highly successful in advanced disease as well as in the adjuvant setting. To determine the potential applicability of such therapies, salivary gland tumours were analysed for HER2?overexpression/amplification in this study.",
keywords = "Humans, Male, Female, Immunohistochemistry, Gene Expression, In Situ Hybridization, Fluorescence, Tissue Array Analysis, Tumor Markers, Biological/genetics/metabolism, *Gene Amplification, Adenocarcinoma/genetics/metabolism/*pathology, Adenoma/genetics/metabolism/*pathology, *Receptor, erbB-2/genetics/metabolism, Salivary Gland Neoplasms/genetics/metabolism/*pathology, Humans, Male, Female, Immunohistochemistry, Gene Expression, In Situ Hybridization, Fluorescence, Tissue Array Analysis, Tumor Markers, Biological/genetics/metabolism, *Gene Amplification, Adenocarcinoma/genetics/metabolism/*pathology, Adenoma/genetics/metabolism/*pathology, *Receptor, erbB-2/genetics/metabolism, Salivary Gland Neoplasms/genetics/metabolism/*pathology",
author = "Till Clauditz and Maren Reiff and Linn Gravert and Alexander Gnoss and Tsourlakis, {Maria Christina} and Adrian M{\"u}nscher and Guido Sauter and Carsten Bokemeyer and Rainald Knecht and Waldemar Wilczak",
year = "2011",
language = "English",
volume = "43",
pages = "459--464",
journal = "PATHOLOGY",
issn = "0031-3025",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

RIS

TY - JOUR

T1 - Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.

AU - Clauditz, Till

AU - Reiff, Maren

AU - Gravert, Linn

AU - Gnoss, Alexander

AU - Tsourlakis, Maria Christina

AU - Münscher, Adrian

AU - Sauter, Guido

AU - Bokemeyer, Carsten

AU - Knecht, Rainald

AU - Wilczak, Waldemar

PY - 2011

Y1 - 2011

N2 - HER2 is a target for antibody-based treatment of breast and gastric carcinoma which is highly successful in advanced disease as well as in the adjuvant setting. To determine the potential applicability of such therapies, salivary gland tumours were analysed for HER2?overexpression/amplification in this study.

AB - HER2 is a target for antibody-based treatment of breast and gastric carcinoma which is highly successful in advanced disease as well as in the adjuvant setting. To determine the potential applicability of such therapies, salivary gland tumours were analysed for HER2?overexpression/amplification in this study.

KW - Humans

KW - Male

KW - Female

KW - Immunohistochemistry

KW - Gene Expression

KW - In Situ Hybridization, Fluorescence

KW - Tissue Array Analysis

KW - Tumor Markers, Biological/genetics/metabolism

KW - Gene Amplification

KW - Adenocarcinoma/genetics/metabolism/pathology

KW - Adenoma/genetics/metabolism/pathology

KW - Receptor, erbB-2/genetics/metabolism

KW - Salivary Gland Neoplasms/genetics/metabolism/pathology

KW - Humans

KW - Male

KW - Female

KW - Immunohistochemistry

KW - Gene Expression

KW - In Situ Hybridization, Fluorescence

KW - Tissue Array Analysis

KW - Tumor Markers, Biological/genetics/metabolism

KW - Gene Amplification

KW - Adenocarcinoma/genetics/metabolism/pathology

KW - Adenoma/genetics/metabolism/pathology

KW - Receptor, erbB-2/genetics/metabolism

KW - Salivary Gland Neoplasms/genetics/metabolism/pathology

M3 - SCORING: Journal article

VL - 43

SP - 459

EP - 464

JO - PATHOLOGY

JF - PATHOLOGY

SN - 0031-3025

IS - 5

M1 - 5

ER -